DESCRIPTION
Session 8: M&A Readiness – When Big Pharma Comes Knocking
BCLT-Oregon Start-Up Series
BCLT Life Sciences Law & Policy Center
Tuesday, Novemner 18, 2025 | 1:00 p.m. | B-CLE
0.75 General CLE Credit Available
Series Info | Resources | Speaker Bios & Contact Info
Mergers and acquisitions can be pivotal moments for biotech and pharmaceutical companies. When “Big Pharma comes knocking,” boards and executives need to be prepared to respond with clarity, confidence, and a solid understanding of their fiduciary responsibilities. This program, led by Lisa Haddad and Caroline Bullerjahn of Goodwin Procter, will guide participants through the key considerations, duties, and processes that ensure organizations are ready when opportunities—or challenges—arise.
What you’ll learn:
- The essentials of fiduciary duties, including duty of care and duty of loyalty
- How to recognize and manage potential conflicts of interest
- Steps boards should take when evaluating strategic alternatives or a potential sale
- Key stages of M&A transactions
- The realities of confidentiality, leaks, and communication challenges during a deal
- Common litigation risks and how to mitigate them
Speaker(s):
Caroline Bullerjahn, Goodwin
Lisa Haddad, Goodwin
Program Series:
Are you a scientist, inventor, entrepreneur, or investor thinking about launching or working with a start-up company? Do you have questions about patents and trade secrets, regulatory requirements, consulting agreements, privacy considerations, and/or IP licensing? The Berkeley Center for Law & Technology and the University of Oregon School of Law have partnered on a new Start-Up Signature Series of virtual legal education programs, designed specifically for start-up companies and their investors. The Start-Up Signature Series will give you the education you need to successfully push your start-up forward!
All programs are free to access.